Eurobio Scientific SA (ALERS.PA) stock: key figures, P/E, revenue and dividend

Health Care · Health Care Equipment · France · ISIN FR0013240934

Price
26.35 EUR
Market cap
270.06 m EUR
P/E (2025)
55.51
P/S (2025)
1.60
Dividend yield
0.00 %
Net margin
2.88 %
Return on equity (ROE)
2.65 %
Return on assets (ROA)
1.89 %

Eurobio Scientific SA financials

Fiscal year20242025
Revenue154.95 m EUR169.00 m EUR
Gross profit71.96 m EUR68.40 m EUR
Operating income13.40 m EUR15.45 m EUR
EBIT12.00 m EUR15.45 m EUR
Net income4.00 m EUR4.87 m EUR
Diluted EPS – continuing operations0.39 EUR0.47 EUR

Full history since 2007, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Eurobio Scientific SA

Eurobio Scientific Société anonyme engages in research, development, and marketing specialty diagnostic products in the areas of transplantation, infectious diseases, autoimmunity, oncology, and life sciences. The company produces and markets transport and preservation media for corneal grafts; AlloMap, for heart transplant follow up; cell culture media, molecular biology reagents, contract manufacturing service, and proprietary antibodies; TQS (Tetanus Quick Stick), a rapid test used in emergency departments or pharmacies to assess the vaccination status or immune protection of patients against tetanus; EBX molecular biology ranges in the field of infectious diseases; and EndoPredict range, a second-generation multigene expression test for postmenopausal women with early-stage breast cancer, ER positive, and HER2 negative, as well as Prolaris. It also provides GenDx, EurobioPlex, FungiLine, Biosafety PKA, and immunology products. The company was formerly known as Diaxonhit and changed its name to Eurobio Scientific Société anonyme in June 2018. Eurobio Scientific Société anonyme was incorporated in 1997 and is headquartered in Les Ulis, France.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 05.11.2026. Details in the risk notice.